JP2003517458A5 - - Google Patents

Download PDF

Info

Publication number
JP2003517458A5
JP2003517458A5 JP2000613411A JP2000613411A JP2003517458A5 JP 2003517458 A5 JP2003517458 A5 JP 2003517458A5 JP 2000613411 A JP2000613411 A JP 2000613411A JP 2000613411 A JP2000613411 A JP 2000613411A JP 2003517458 A5 JP2003517458 A5 JP 2003517458A5
Authority
JP
Japan
Prior art keywords
groups
term
alkyl
group
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000613411A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003517458A (ja
JP4726304B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2000/000494 external-priority patent/WO2000064420A2/en
Publication of JP2003517458A publication Critical patent/JP2003517458A/ja
Publication of JP2003517458A5 publication Critical patent/JP2003517458A5/ja
Application granted granted Critical
Publication of JP4726304B2 publication Critical patent/JP4726304B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000613411A 1999-04-28 2000-04-28 アミロイドーシスを治療するための組成物および方法 Expired - Fee Related JP4726304B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US13146499P 1999-04-28 1999-04-28
US60/131,464 1999-04-28
US13554599P 1999-05-24 1999-05-24
US60/135,545 1999-05-24
US14312399P 1999-07-09 1999-07-09
US60/143,123 1999-07-09
PCT/CA2000/000494 WO2000064420A2 (en) 1999-04-28 2000-04-28 Compositions and methods for treating amyloidosis using sulphonate derivatives

Publications (3)

Publication Number Publication Date
JP2003517458A JP2003517458A (ja) 2003-05-27
JP2003517458A5 true JP2003517458A5 (cg-RX-API-DMAC7.html) 2011-04-14
JP4726304B2 JP4726304B2 (ja) 2011-07-20

Family

ID=27384158

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000613411A Expired - Fee Related JP4726304B2 (ja) 1999-04-28 2000-04-28 アミロイドーシスを治療するための組成物および方法

Country Status (16)

Country Link
US (3) US20040198832A1 (cg-RX-API-DMAC7.html)
EP (1) EP1276483B1 (cg-RX-API-DMAC7.html)
JP (1) JP4726304B2 (cg-RX-API-DMAC7.html)
KR (2) KR20070094996A (cg-RX-API-DMAC7.html)
CN (1) CN100482233C (cg-RX-API-DMAC7.html)
AT (1) ATE441421T1 (cg-RX-API-DMAC7.html)
AU (1) AU4282400A (cg-RX-API-DMAC7.html)
BR (1) BR0010099A (cg-RX-API-DMAC7.html)
CA (1) CA2369997C (cg-RX-API-DMAC7.html)
DE (1) DE60042896D1 (cg-RX-API-DMAC7.html)
DK (1) DK1276483T3 (cg-RX-API-DMAC7.html)
ES (1) ES2331905T3 (cg-RX-API-DMAC7.html)
IL (1) IL146143A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA01010835A (cg-RX-API-DMAC7.html)
NZ (1) NZ543319A (cg-RX-API-DMAC7.html)
WO (1) WO2000064420A2 (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
US6562836B1 (en) 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
WO2001003680A2 (en) * 1999-07-09 2001-01-18 Isis Innovation Limited Compounds for inhibiting diseases and preparing cells for transplantation
US7311893B2 (en) 2000-07-25 2007-12-25 Neurochem (International) Limited Amyloid targeting imaging agents and uses thereof
US6716589B2 (en) 2000-11-20 2004-04-06 Alphabeta Ab Discordant helix stabilization for prevention of amyloid formation
WO2004016261A1 (en) * 2002-08-12 2004-02-26 Yuuichi Murayama Method for suppressing proliferation of abnormal prion protein with leucine, isoleucine or valine
CA2511599A1 (en) * 2002-12-24 2004-07-15 Neurochem (International) Limited Therapeutic formulations for the treatment of beta-amyloid related diseases
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
AU2004249529A1 (en) * 2003-06-23 2004-12-29 Bellus Health (International) Limited Methods and compositions for treating amyloid-related diseases
JP2007516940A (ja) * 2003-06-23 2007-06-28 ニューロケム (インターナショナル) リミテッド 改善された薬剤候補およびその調製法
US20050142191A1 (en) * 2003-06-23 2005-06-30 Neurochem (International) Limited Pharmaceutical formulations of amyloid inhibiting compounds
AU2011250847B2 (en) * 2003-06-23 2013-06-20 Bhi Limited Partnership Methods and compositions for treating amyloid-related diseases
US7253306B2 (en) 2003-06-23 2007-08-07 Neurochem (International) Limited Pharmaceutical drug candidates and methods for preparation thereof
WO2006059252A2 (en) * 2004-11-12 2006-06-08 Neurochem (International) Limited Methods and fluorinated compositions for treating amyloid-related diseases
CN101103018A (zh) * 2004-11-16 2008-01-09 神经化学(国际)有限公司 治疗cns和淀粉样蛋白-相关疾病的化合物
US8044100B2 (en) * 2004-12-22 2011-10-25 Bellus Health Inc. Methods and compositions for treating amyloid-related diseases
TW200716088A (en) 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
CN101600730B (zh) 2006-10-12 2014-01-29 Bhi有限合资公司 递送3-氨基-1-丙磺酸的方法、化合物、组合物和载体
KR100883132B1 (ko) 2006-10-24 2009-02-10 재단법인서울대학교산학협력재단 아밀로이드 형성 펩타이드 또는 단백질의 가용성 회합체에선택적으로 작용하는 절단제
CA2676715A1 (en) 2007-02-12 2008-08-21 Merck & Co., Inc. Piperazine derivatives for treatment of ad and related conditions
CN102076678A (zh) * 2008-07-10 2011-05-25 诺瓦提斯公司 作为bace抑制剂的具有氨基苄基取代基的环砜类化合物
KR102657460B1 (ko) 2015-08-10 2024-04-12 알제온, 인크. 신경퇴행성 장애를 치료 및 예방하기 위한 조성물 및 방법
WO2018156845A1 (en) * 2017-02-24 2018-08-30 Alzheon, Inc. Methods for treating neurodegenerative disorders
USD852236S1 (en) 2017-08-17 2019-06-25 Samsung Electronics Co., Ltd. Refrigerator
US20250345298A1 (en) 2022-04-28 2025-11-13 Alzheon, Inc. Apoe4 correctors and methods of use
CN120641092A (zh) 2022-12-02 2025-09-12 阿尔泽恩股份有限公司 用于用曲米沙特治疗神经变性病症的方法

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2531468A (en) * 1949-04-14 1950-11-28 Eastman Kodak Co Polyvinyl sulfonates and process for their preparation
DE1122064B (de) * 1960-01-09 1962-01-18 Basf Ag Verfahren zur Einfuehrung von alyphatischen Kohlenwasserstoffresten in organische Verbindungen, die Hydroxylgruppen, tertiaere Aminogruppen, aromatische gebundene Sulfhydrylgruppen und bzw. oder aromatisch gebundene primaere oder sekundaere Aminogruppen enthalten
US3218352A (en) * 1962-05-03 1965-11-16 Abbott Lab Homotaurine process
US3658966A (en) * 1969-09-15 1972-04-25 Kowa Co Methods of treating hypertension
US3920833A (en) * 1974-08-08 1975-11-18 Stanley Drug Products Inc Antifibrinolytic agents
FR2384751A1 (fr) * 1977-03-23 1978-10-20 Francaise Coop Pharma Nouveaux derives de la taurine a activite neuro-musculaire renforcee
CA1144937A (en) * 1977-12-22 1983-04-19 Dke J.E. Helgstrand Aromatic derivatives, pharmaceutical compositions and methods for combatting virus infections
FR2457281A1 (fr) * 1979-05-23 1980-12-19 Meram Lab Nouveaux derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee
US4255448A (en) * 1979-09-10 1981-03-10 Wisconsin Alumni Research Foundation Method for reducing epileptiform activity
US4448779A (en) * 1981-07-16 1984-05-15 Sanofi Use of MS salt in geriatric medicine
JPS5879022A (ja) * 1981-11-04 1983-05-12 Bitamin Kenkyusho:Kk 第四級窒素原子を含有する新規な金属架橋高分子化合物、その製法及び該高分子化合物を有効成分とする高脂血症治療剤
US4540564A (en) * 1982-05-18 1985-09-10 University Of Florida Brain-specific drug delivery
US5087618A (en) * 1982-05-18 1992-02-11 University Of Florida Redox carriers for brain-specific drug delivery
FR2529546A1 (fr) * 1982-07-05 1984-01-06 Meram Lab Nouveaux sels d'amino-(et imino-)acides a, o-sulfoniques n-substitues, vecteurs cationiques de haute penetration cellulaire
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
DE3229300A1 (de) * 1982-08-05 1984-02-09 Haarmann & Reimer Gmbh, 3450 Holzminden Aliphatische dicarbonsaeureester als riechstoffe und diese enthaltende parfuemkompositionen und parfuemierte produkte
US4737353A (en) * 1984-04-13 1988-04-12 Union Carbide Corporation Beryllium-aluminum-phosphorus-silicon-oxide molecular sieve compositions
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
MX9203291A (es) * 1985-06-26 1992-08-01 Liposome Co Inc Metodo para acoplamiento de liposomas.
JPH0786122B2 (ja) * 1986-05-30 1995-09-20 日本ペイント株式会社 三次元架橋された微小樹脂粒子およびその製造法
US4847082A (en) * 1987-01-21 1989-07-11 Robert Sabin Method of treatment of Alzheimer's disease using phytic acid
US5166320A (en) * 1987-04-22 1992-11-24 University Of Connecticut Carrier system and method for the introduction of genes into mammalian cells
IT1205042B (it) * 1987-05-28 1989-03-10 Crinos Industria Farmaco Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer
US5108921A (en) * 1989-04-03 1992-04-28 Purdue Research Foundation Method for enhanced transmembrane transport of exogenous molecules
US5194654A (en) * 1989-11-22 1993-03-16 Vical, Inc. Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
US5463092A (en) * 1989-11-22 1995-10-31 Vestar, Inc. Lipid derivatives of phosphonacids for liposomal incorporation and method of use
US5242932A (en) * 1991-12-17 1993-09-07 The Rockefeller University Treatment of amyloidosis associated with alzheimer disease
US5385915A (en) * 1990-05-16 1995-01-31 The Rockefeller University Treatment of amyloidosis associated with Alzheimer disease using modulators of protein phosphorylation
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
US5164295A (en) * 1991-03-06 1992-11-17 The Upjohn Company Method for identifying amyloid protein-extracellular matrix protein affinity altering compounds
US5192753A (en) * 1991-04-23 1993-03-09 Mcgeer Patrick L Anti-rheumatoid arthritic drugs in the treatment of dementia
DE59207848D1 (de) * 1991-12-19 1997-02-20 Ciba Geigy Ag Aminosulfonsäurederivate und Verfahren zu ihrer Herstellung
US5276059A (en) * 1992-07-10 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of diseases associated with amyloid formation
US5840294A (en) * 1993-03-29 1998-11-24 Queen's University At Kingston Method for treating amyloidosis
US5972328A (en) * 1993-03-29 1999-10-26 Queen's University At Kingston Method for treating amyloidosis
US5643562A (en) * 1993-03-29 1997-07-01 Queen's University Of Kingston Method for treating amyloidosis
US5646562A (en) * 1993-07-21 1997-07-08 Seiko Epson Corporation Phase synchronization circuit, one-shot pulse generating circuit and signal processing system
US5488145A (en) * 1993-12-23 1996-01-30 Oklahoma Medical Research Foundation 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps
US5858326A (en) * 1995-06-06 1999-01-12 Neurochem, Inc. Methods of increasing amyloid deposition
DE19531342B4 (de) * 1995-08-25 2007-11-29 Merz Pharma Gmbh & Co. Kgaa Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren
AU703540B2 (en) * 1996-03-26 1999-03-25 Meddiss, Incorporated Methods for inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
CA2217322C (en) * 1996-10-03 2005-01-04 Coastside Bio Resources Inhibition of complement pathway by sea cucumber fractions
DE69842048D1 (de) * 1997-08-01 2011-01-27 Max Planck Gesellschaft Zusammensetzung und verfahren zum nachweis von krankheiten in zusammenhang mit der bildung von amyloid-ähnlichen fibrillen oder protein-aggregaten
NZ550116A (en) * 1997-08-18 2008-03-28 Neurochem Int Ltd Phosphono-carboxylate compounds for treating amyloidosis
US6294583B1 (en) * 1998-01-13 2001-09-25 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders
WO1999040909A1 (en) * 1998-02-11 1999-08-19 Neurochem, Inc. Method for modulating macrophage activation
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
US6329356B1 (en) * 1998-04-10 2001-12-11 Neurochem, Inc. Phosphono-carboxylate compounds for treating amyloidosis
US6310073B1 (en) * 1998-07-28 2001-10-30 Queen's University At Kingston Methods and compositions to treat glycosaminoglycan-associated molecular interactions
US6562836B1 (en) * 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
US20070135337A2 (en) * 1999-11-29 2007-06-14 Neurochem (International) Limited Vaccine for the Prevention and Treatment of Alzheimer's and Amyloid Related Diseases
US6376557B1 (en) * 2000-03-16 2002-04-23 Chanda Bhuwalka Zaveri Methods for treating alopecia
EP1386166A2 (en) * 2001-03-13 2004-02-04 Queen's University At Kingston Anti-epileptogenic agents
IL160208A0 (en) * 2001-08-31 2004-07-25 Neurochem Int Ltd Amidine derivatives for treating amyloidosis
US20040096553A1 (en) * 2002-11-20 2004-05-20 James E. Lynch Ice cream cone drip guard
US20050142191A1 (en) * 2003-06-23 2005-06-30 Neurochem (International) Limited Pharmaceutical formulations of amyloid inhibiting compounds
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7253306B2 (en) * 2003-06-23 2007-08-07 Neurochem (International) Limited Pharmaceutical drug candidates and methods for preparation thereof
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
US20080038192A1 (en) * 2004-07-19 2008-02-14 Neurochem Inc. Diagnostic Methods Of Multiple Organ Amyloidosis
US8044100B2 (en) * 2004-12-22 2011-10-25 Bellus Health Inc. Methods and compositions for treating amyloid-related diseases

Similar Documents

Publication Publication Date Title
JP2003517458A5 (cg-RX-API-DMAC7.html)
WO2002003984A3 (en) Anticonvulsant derivatives useful for treating and preventing the development of type ii diabetes mellitus and syndrome x
MY134664A (en) 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipedemia
WO2005033230A3 (en) Low-cure powder coatings, related coating method and coated substrates
WO2000042996A3 (en) Use of anticonvulsant derivatives for treating cluster headaches
AR022323A1 (es) Complejo del inhibidor de ras-farnesiltransferasa y sulfobutileter-7-beta-ciclodextrina o 2-hidroxipropil-beta-ciclodextrina y composiciones formuladas condicho complejo
GB2280433B (en) Liquid injection molding inhibitors for curable compositions
WO2004114371A3 (de) Verbindung zur bildung einer selbstorganisierenden monolage, schichtstruktur, halbleiterbauelement mit einer schichtstruktur und verfahren zur herstellung einer schichtstruktur
EP1284266A4 (en) NEW INDOIND DERIVATIVES WITH CHYME-INHIBITABLE ACTIVITIES AND METHOD FOR THEIR PREPARATION
WO2003059900A1 (en) Coumarin derivatives, process for their production and use thereof
WO1999009965A3 (en) Anti-inflammatory agent
WO2003059907A1 (en) Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof
BG104034A (en) Method for the preparation of pharmaceutical compounds of antidepressive effect and against the parkinson syndrome effect
BR9405608A (pt) Processo para preparaçào de polìmeros contendo lignina
EP1506777A4 (en) MEANS FOR PREVENTING OR REDUCING FAT SUPPORT WITH A METHYLIDENHYDRAZIDE COMPOUND AS AN ACTIVE SUBSTANCE
Chen et al. Synthesis and bioactivity evaluation of 3‐hydroxy‐3‐(phenylethynyl) indol‐2‐one analogues
DE60228053D1 (de) Benzamidinderivate mit entzündungshemmender und immunsuppressiver wirkung
MX173689B (es) Procedimiento para la fabricacion de multicapas de polimida gruesas
ES454165A1 (es) Un procedimiento para la preparacion de 3',4'-didesiva en superficie de poliester.
EP1403253A4 (en) NEW HETEROCYCLIC CONNECTION AND THEIR MEDICAL USE
JPS5473900A (en) Curable resin composition
IE38821B1 (en) Thiophene derivatives process for their preparation and compositions incorporating them
EP1273587A4 (en) METHOD FOR PRODUCING A 3-VINYL CEPHEM COMPOUND
KR950010897A (ko) 신규의 화학적 보호제(chemopreventive agent) 및 그의 제조방법
TW200609271A (en) Soluble polymide and optical compensation member using the same